Infections of Helicobacter spp. in the biliary system are associated with biliary tract cancer: A meta-analysis

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 4, 2013, Pages 447-454

  Zhou, Di ^a   Wang, Jian Dong ^a   Weng, Ming Zhe ^a   Zhang, Yong ^a   Wang, Xue Feng ^a   Gong, Wei ^a   Quan, Zhi Wei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

biliary tract cancer; Helicobacter spp.; meta analysis

Indexed keywords

ARTICLE; ASSOCIATION; BILIARY TRACT CANCER; BILIARY TRACT DISEASE; CELL HETEROGENEITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER; HELICOBACTER BILIS; HELICOBACTER GANMANI; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNOHISTOCHEMISTRY; INFORMATION RETRIEVAL; META ANALYSIS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RISK; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

BILIARY TRACT DISEASES; BILIARY TRACT NEOPLASMS; CHOLELITHIASIS; HELICOBACTER; HELICOBACTER INFECTIONS; HUMANS; PREVALENCE;

EID: 84875177727     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835c0362     Document Type: Article

References (35)

1. Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A, et al. Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998. Gut 2001; 48:816-820.
2. Patel T. Increasing incidence and mortality of primary intrahepatic cholangio-carcinoma in the United States. Hepatology 2001; 33:1353-1357.
3. Furuse J, Takada T, Miyazaki M, Miyakawa S, Tsukada K, Nagino M, et al. Guidelines for chemotherapy of biliary tract and ampullary carcinomas. J Hepatobiliary Pancreat Surg 2008; 15:55-62.
4. Watanabe T, Tada M, Nagai H, Sasaki S, Nakao M. Helicobacter pylori infection induces gastric cancer in Mongolian gerbils. Gastroenterology 1998; 115:642-648.
5. Nilsson HO, Taneera J, Castedal M, Glatz E, Olsson R, Wadström T. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 38:1072-1076.
6. Zhou D, Zhang Y, Gong W, Mohamed SO, Ogbomo H, Wang X, et al. Are Helicobacter pylori and other Helicobacter species infection associated with human biliary lithiasis? A meta-analysis. PLoS One 2011; 6:e27390.
7. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. QUOROM Group. Br J Surg 2000; 87: 1448-1454.
8. Arena VC. A program to compute the generalized Mantel-Haenszel chi-square for multiple 2 x J tables. Comput Programs Biomed 1983; 17: 65-72.
9. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
10. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629-634.
11. Bulajic M, Maisonneuve P, Schneider-Brachert W, Müller P, Reischl U, Stimec B, et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002; 95:1946-1953.
12. Fukuda K, Kuroki T, Tajima Y, Tsuneoka N, Kitajima T, Matsuzaki S, et al. Comparative analysis of Helicobacter DNAs and biliary pathology in patients with and without hepatobiliary cancer. Carcinogenesis 2002; 23:1927-1931.
13. Matsukura N, Yokomuro S, Yamada S, Tajiri T, Sundo T, Hadama T, et al. Association between Helicobacter bilis in bile and biliary tract malignancies: H. bilis in bile from Japanese and Thai patients with benign and malignant diseases in the biliary tract. Jpn J Cancer Res 2002; 93:842-847.
14. Murata H, Tsuji S, Tsujii M, Fu HY, Tanimura H, Tsujimoto M, et al. Helicobacter bilis infection in biliary tract cancer. Aliment Pharmacol Ther 2004; 20 (Suppl 1):90-94.
15. Kobayashi T, Harada K, Miwa K, Nakanuma Y Helicobacter genus DNA fragments are commonly detectable in bile from patients with extrahepatic biliary diseases and associated with their pathogenesis. Dig Dis Sci 2005; 50:862-867.
16. Tiwari SK, Khan AA, Ibrahim M, Habeeb MA, Habibullah CM. Helicobacter pylori and other Helicobacter species DNA in human bile samples from patients with various hepato-biliary diseases. World J Gastroenterol 2006; 12:2181-2186.
17. Bohr UR, Kuester D, Meyer F, Wex T, Stillert M, Csepregi A, et al. Low prevalence of Helicobacteraceae in gall-stone disease and gall-bladder carcinoma in the German population. Clin Microbiol Infect 2007; 13: 525-531.
18. Shimoyama T, Takahashi R, Abe D, Mizuki I, Endo T, Fukuda S. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol 2010; 25 (Suppl 1): S86-S89.
19. Yakoob J, Khan MR, Abbas Z, Jafri W, Azmi R, Ahmad Z, et al. Helicobacter pylori: association with gall bladder disorders in Pakistan. Br J Biomed Sci 2011; 68:59-64.
20. Mishra RR, Tewari M, Shukla HS. Helicobacter pylori and pathogenesis of gallbladder cancer. J Gastroenterol Hepatol 2011; 26:260-266.
21. Hattori T, Sugihara H. The pathological sequence in the development of gastric cancer: I. Scand J Gastroenterol Suppl 1996; 214:34-35.
22. Buck JL, Pantongrag-Brown L. Gastritides, gastropathies, and polyps unique to the stomach. Radiol Clin North Am 1994; 32:1215-1231.
23. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ Jr, et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994; 86:1222-1227.
24. Fox JG, Li X, Yan L, Cahill RJ, Hurley R, Lewis R, et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of Helicobacter-induced carcinogenesis. Infect Immun 1996; 64:1548-1558.
25. Fox JG, Yan LL, Dewhirst FE, Paster BJ, Shames B, Murphy JC, et al. Helicobacter bilis sp. nov., a novel Helicobacter species isolated from bile, livers, and intestines of aged, inbred mice. J Clin Microbiol 1995; 33:445-454.
26. On SL. Identification methods for Campylobacters, Helicobacters, and related organisms. Clin Microbiol Rev 1996; 9:405-422.
27. Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J Clin Microbiol 1992; 30:192-200.
28. Labigne A, Cussac V, Courcoux P. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J Bacteriol 1991; 173:1920-1931.
29. Roe IH, Kim JT, Lee HS, Lee JH. Detection of Helicobacter DNA in bile from bile duct diseases. J Korean Med Sci 1999; 14:182-186.
30. Mégraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev 2007; 20:280-322.
31. Dore MP, Osato M, Malaty HM, Graham DY. Characterization of a culture method to recover Helicobacter pylori from the feces of infected patients. Helicobacter 2000; 5:165-168.
32. Brown LM. Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 2000; 22:283-297.
33. Everhart JE, Kruszon-Moran D, Perez-Perez GI, Tralka TS, McQuillan G. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 2000; 181:1359-1363.
34. Shiota S, Murakami K, Fujioka T, Yamaoka Y. Population-based strategies for Helicobacter pylori-associated disease management: a Japanese perspective. Expert Rev Gastroenterol Hepatol 2010; 4:149-156.
35. Agha A, Graham DY. Evidence-based examination of the African enigma in relation to Helicobacter pylori infection. Scand J Gastroenterol 2005; 40:523-529.